Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells in New-onset Type 1 Diabetes
NCT04078308Phase 2Unknown
- Sponsor
- Royan Institute
- Start
- Jul 2015
- Primary completion
- Sep 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow derived mesenchymal stromal cells in type 1 diabetes mellitus (T1D), sponsored by Royan Institute. Status: unknown.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04078308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04078308.